/
/
/

Asston Pharmaceuticals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
--38%61%
--239%218%
---72%
42%42%52%51%

Peer Comparison

Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
LAURUSLABS-A
ZYDUSLIFE-A
DRREDDY-A
CIPLA-A
MANKIND-A
AUROPHARMA-A
LUPIN-A
APL-MT
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,771.95₹424202 Cr38.688.2958.23₹11479 Cr
10,030₹264141 Cr90.334.04128.41₹2568 Cr
4,635₹174402 Cr82.1114.04106.21₹2163 Cr
2,320₹126811 Cr94.648.1733.94₹889 Cr
1,239₹123685 Cr27.419.4262.53₹5040 Cr
1,370₹111868 Cr39.9511.0859.2₹4196 Cr
1,392.2₹111650 Cr38.5410.8652.6₹3879 Cr
2,477.1₹102196 Cr45.5717.2376.26₹1913 Cr
1,699₹96951 Cr26.1117.9596.84₹3505 Cr
2,012₹91301 Cr16.5130.95154.35₹5333 Cr
143.05₹164 Cr42.56—3.83₹4 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022
————
₹6 Cr₹78 L₹70 L₹70 L
₹4 Cr₹6 Cr₹1 Cr₹23 L
₹4 Cr₹6 Cr₹1 Cr₹23 L
₹11 Cr₹6 Cr₹2 Cr₹93 L
₹14 L₹91 L₹97 L₹69 L
₹2 Cr₹72 L₹85 L₹25 L
-₹2 L₹2 L₹3 L₹2 L
₹16 L₹16 L₹7 L₹5 L
₹2 Cr₹2 Cr₹2 Cr₹1 Cr
————
₹6 Cr₹6 Cr₹6 Cr₹5 Cr
₹3 Cr₹83 L₹45 L₹51 L
₹4 Cr₹5 Cr₹3 Cr₹2 Cr
₹2 Cr₹86 L₹67 L₹20 L
₹15 Cr₹12 Cr₹10 Cr₹8 Cr
₹28 Cr₹20 Cr₹14 Cr₹9 Cr
₹7 Cr₹7 Cr₹5 Cr₹3 Cr
————
₹1 Cr₹1 Cr₹1 Cr₹94 L
₹14 L₹11 L₹6 L₹3 L
₹96 L₹1 Cr₹1 Cr₹92 L
₹13 L₹13 L₹1 Cr₹1 Cr
₹0₹71 L₹67 L₹0
₹1 Cr₹2 Cr₹3 Cr₹2 Cr
————
₹72 L₹1 Cr₹2 Cr₹50 L
₹25 Cr₹16 Cr₹9 Cr₹6 Cr
₹20 L₹64,000₹12 L₹14 L
₹1 L₹0₹0₹0
₹2 Cr₹74 L₹46 L₹34 L
₹27 Cr₹18 Cr₹11 Cr₹7 Cr
₹12 Cr₹6 Cr₹91 L-₹18 L
₹28 Cr₹20 Cr₹14 Cr₹9 Cr
₹17₹82₹28₹13
₹17₹10₹4₹2

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022
₹6 Cr₹2 Cr₹1 Cr₹16 L
₹93 L₹94 L₹75 L₹44 L
-₹7 Cr-₹6 Cr-₹2 Cr-₹2 Cr
-₹17 L-₹3 Cr-₹30 L-₹1 Cr
-₹16 L-₹4 Cr-₹32 L-₹1 Cr
₹87 L-₹54,000-₹91 L-₹20,000
-₹51 L₹4 Cr₹1 Cr₹1 Cr
₹19 L-₹12 L-₹1 L₹10 L
₹63,000₹12 L₹14 L₹3 L
₹20 L₹64,000₹12 L₹14 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)148.00
Volume (₹)27,000.00
High (₹)148.00
Upper Circuit158.05
Low (₹)143.05
Lower Circuit143.05
Prev Close150.55
52W High (₹)153.40
Price143.05
52W Low (₹)60.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)164.44 Cr
Div. Yield (%)0.00
PE Ratio42.56
Debt to Equity0.68
Price to Book0.00
Book Value17.09
EPS (TTM)3.54
Face Value10.00
ROE (%)50.56

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
APL-MTNSE
LTP
1W Low
1W High
Market cap (₹)
1771.95-6.3 (-0.35%)
1720.80
1854.80
4,24,202Cr
10030+315 (3.24%)
9622.85
10035
2,64,141Cr
4635-0.15 (-0.00%)
4555
4668.55
1,74,402Cr
2320-72 (-3.01%)
2207.10
2442
1,26,811Cr
1239-5 (-0.40%)
1184.55
1264.20
1,23,685Cr
1370+19.8 (1.47%)
1337.30
1390.70
1,11,868Cr
1392.2+12.2 (0.88%)
1360.60
1392.20
1,11,650Cr
2477.1-11.65 (-0.47%)
2457.35
2527.80
1,02,196Cr
1699+21.2 (1.26%)
1650.10
1699
96,951Cr
2012+3 (0.15%)
1974.05
2032
91,301Cr
143.05-7.67 (-5.09%)
143.05
153.40
164Cr

Asston Pharmaceuticals Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Asston Pharmaceuticals Ltd Quaterly Results Key Takeaways